Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
L. Casares, R. Moreno, M. Higgins…·L. de la Vega
This study identifies CDDO-derivatives as BACH1 inhibitors, explaining their higher potency as HMOX1 inducers compared to CDDO.
D. Olagnier, E. Farahani, J. Thyrsted…·C. K. Holm
The paper identifies NRF2 agonists 4-OI and DMF as inhibitors of SARS-CoV2 replication and inflammatory responses, effective against multiple viruses.
E. B. Svenningsen, J. T. Jensen, J. Blay-Cadanet…·T. B. Poulsen
This study identifies X-206, a polyether ionophore antibiotic, as a potent and selective inhibitor of SARS-CoV-2 infection in vitro with high selectivity and sub-nM efficacy.
B. K. Hansen, C. K. Larsen, J. T. Nielsen…·T. B. Poulsen
This study investigates phenomycin's mechanism of toxicity, showing it inhibits translation initiation, requires endosomal escape for toxicity, and identifies a critical structural loop for its activity.